Characterization of New Specific Copper Chelators as Potential Drugs for the Treatment of Alzheimer’s Disease

The Catalytically Active Copper-Amyloid-Beta State: Coordination Site Responsible for Reactive Oxygen Species Production

(2013) Laure-Estelle Cassagnes et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Binding of transition metal ions to albumin: Sites, affinities and rates

(2013) Wojciech Bal et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Mapping the Interactions between the Alzheimer’s Aβ-Peptide and Human Serum Albumin beyond Domain Resolution

(2013) Moustafa Algamal et al.   BIOPHYSICAL JOURNAL

Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis

(2013) Kit Yee Chan et al.   LANCET

Therapeutic Redistribution of Metal Ions To Treat Alzheimer’s Disease

(2012) Peter J. Crouch et al.   ACCOUNTS OF CHEMICAL RESEARCH

Cu(II) Affinity for the Alzheimer’s Peptide: Tyrosine Fluorescence Studies Revisited

(2012) Bruno Alies et al.   ANALYTICAL CHEMISTRY

Charting the travels of copper in eukaryotes from yeast to mammals

(2012) Tracy Nevitt et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Werner coordination chemistry and neurodegeneration

(2012) Maria A. Telpoukhovskaia et al.   CHEMICAL SOCIETY REVIEWS

A Bioinorganic View of Alzheimer’s Disease: When Misplaced Metal Ions (Re)direct the Electrons to the Wrong Target

(2012) Peter Faller et al.   CHEMISTRY-A EUROPEAN JOURNAL

Human Serum Albumin Can Regulate Amyloid-β Peptide Fiber Growth in the Brain Interstitium

(2012) Helen F. Stanyon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Copper Chelator Induced Efficient Episodic Memory Recovery in a Non-Transgenic Alzheimer’s Mouse Model

(2012) Johnatan Ceccom et al.   PLoS One

Solubility and pKa determination of six structurally related phenothiazines

(2011) Urszula Domańska et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Unification of the Copper(I) Binding Affinities of the Metallo-chaperones Atx1, Atox1, and Related Proteins

(2011) Zhiguang Xiao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Alzheimer’s therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity

(2011) Peter J. Crouch et al.   JOURNAL OF NEUROCHEMISTRY

Optical, Magnetic, Electrochemical, and Electrical Properties of 8-Hydroxyquinoline-Based Complexes with Al3+, Cr3+, Mn2+, Co2+, Ni2+, Cu2+, and Zn2+

(2011) Lorena M. A. Monzon et al.   Journal of Physical Chemistry C

Human serum albumin: From bench to bedside

(2011) Gabriella Fanali et al.   MOLECULAR ASPECTS OF MEDICINE

Alzheimer's disease: clinical trials and drug development

(2010) Francesca Mangialasche et al.   LANCET NEUROLOGY

Alzheimer's disease: strategies for disease modification

(2010) Martin Citron   NATURE REVIEWS DRUG DISCOVERY

Copper(II) Binding to Amyloid-β Fibrils of Alzheimer’s Disease Reveals a Picomolar Affinity: Stoichiometry and Coordination Geometry Are Independent of Aβ Oligomeric Form

(2009) Claire J. Sarell et al.   BIOCHEMISTRY

The disproportionation of Cu(I)X mediated by ligand and solvent into Cu(0) and Cu(II)X2and its implications for SET-LRP

(2009) Brad M. Rosen et al.   JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY

Preparation of New Bis(8-aminoquinoline) Ligands and Comparison with Bis(8-hydroxyquinoline) Ligands on Their Ability to Chelate CuIIand ZnII

(2008) Céline Deraeve et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Preparation and Study of New Poly-8-Hydroxyquinoline Chelators for an anti-Alzheimer Strategy

(2007) Céline Deraeve et al.   CHEMISTRY-A EUROPEAN JOURNAL

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

(2003) Craig S. Atwood et al.   JOURNAL OF NEUROCHEMISTRY